VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 295 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $285,000 | +17.8% | 12,301 | -18.5% | 0.01% | +22.2% |
| Q1 2018 | $242,000 | +3.4% | 15,101 | +33.6% | 0.01% | 0.0% |
| Q4 2017 | $234,000 | +39.3% | 11,301 | -3.1% | 0.01% | +28.6% |
| Q3 2017 | $168,000 | -41.5% | 11,665 | -29.2% | 0.01% | -46.2% |
| Q2 2017 | $287,000 | +126.0% | 16,465 | +52.4% | 0.01% | +85.7% |
| Q1 2017 | $127,000 | -49.4% | 10,807 | +5.8% | 0.01% | -46.2% |
| Q3 2016 | $251,000 | -11.6% | 10,212 | +268.1% | 0.01% | -13.3% |
| Q4 2015 | $284,000 | -28.5% | 2,774 | +23.9% | 0.02% | -31.8% |
| Q3 2015 | $397,000 | -32.7% | 2,239 | -15.7% | 0.02% | -15.4% |
| Q2 2015 | $590,000 | +159.9% | 2,656 | +134.2% | 0.03% | +73.3% |
| Q1 2015 | $227,000 | – | 1,134 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,577,892 | $994,984,000 | 31.62% |
| Ruane, Cunniff & Goldfarb | 33,922,192 | $6,051,041,000 | 31.06% |
| LeVasseur Capital Partners LLC | 162,394 | $28,968,000 | 29.76% |
| FARLEY CAPITAL L.P. | 192,130 | $34,272,000 | 27.18% |
| Pershing Square Capital Management | 19,473,933 | $3,473,760,000 | 24.90% |
| Arrow Capital Management, LLC | 109,461 | $19,525,000 | 16.53% |
| Marble Arch Investments | 1,196,900 | $213,503,000 | 16.43% |
| Tesuji Partners | 1,368,040 | $244,414,000 | 15.82% |
| ValueAct Holdings | 14,994,261 | $2,674,676,000 | 15.55% |
| Hound Partners | 3,898,648 | $695,441,000 | 15.04% |